Lucid Diagnostics (LUCD) Long-Term Debt Issuances (2020 - 2025)
Lucid Diagnostics posted quarterly Long-Term Debt Issuances of $360000.0 for Q1 2025, down 96.4% on a QoQ basis from $10.0 million in Q1 2023.
Lucid Diagnostics (LUCD) has 4 years of Long-Term Debt Issuances data on file, last reported at $360000.0 in Q1 2025.
- For the quarter ending Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $360000.0; the trailing twelve-month figure through Dec 2025 stood at $360000.0 (changed N/A YoY), and the FY2025 full-year result was $360000.0, down 98.33% from the prior year.
- Long-Term Debt Issuances for Q1 2025 stood at $360000.0, down from $10.0 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $10.0 million in Q1 2023 and bottomed at $360000.0 in Q1 2025.
- The 3-year median for Long-Term Debt Issuances is $3.9 million (2021), against an average of $4.5 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lucid Diagnostics | 145.00 Mn | 117.12 Mn | -325,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 360,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Mar 31, 2023 | 10.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Jun 30, 2021 | 4.44 Mn |
| Jun 30, 2021 | 4.44 Mn |
| Mar 31, 2021 | 3.30 Mn |
| Mar 31, 2021 | 3.30 Mn |
| Dec 31, 2020 | 1.60 Mn |
| Dec 31, 2020 | 1.60 Mn |